BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8532135)

  • 1. Adenosine receptors.
    Palmer TM; Stiles GL
    Neuropharmacology; 1995 Jul; 34(7):683-94. PubMed ID: 8532135
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine receptors: new opportunities for future drugs.
    Poulsen SA; Quinn RJ
    Bioorg Med Chem; 1998 Jun; 6(6):619-41. PubMed ID: 9681130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The past, present and future of purine nucleotides as signalling molecules.
    Burnstock G
    Neuropharmacology; 1997 Sep; 36(9):1127-39. PubMed ID: 9364468
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine A3 receptor and brain. A culprit, a hero, or merely yet another receptor?
    von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():49-67. PubMed ID: 9369974
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
    Agarwal R; Agarwal P
    Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.
    Dalziel HH; Westfall DP
    Pharmacol Rev; 1994 Dec; 46(4):449-66. PubMed ID: 7899473
    [No Abstract]   [Full Text] [Related]  

  • 7. GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain.
    Kull B; Svenningsson P; Hall H; Fredholm BB
    Neuropharmacology; 2000 Sep; 39(12):2374-80. PubMed ID: 10974321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine inhibits a non-inactivating K+ current in bovine adrenal cortical cells by activation of multiple P1 receptors.
    Xu L; Enyeart JJ
    J Physiol; 1999 Nov; 521 Pt 1(Pt 1):81-97. PubMed ID: 10562336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.
    Franco R; Ferré S; Agnati L; Torvinen M; Ginés S; Hillion J; Casadó V; Lledó P; Zoli M; Lluis C; Fuxe K
    Neuropsychopharmacology; 2000 Oct; 23(4 Suppl):S50-9. PubMed ID: 11008067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine mediates the effects of ethanol on the cAMP signal transduction system.
    Gordon AS; Diamond I
    Alcohol Alcohol Suppl; 1993; 2():437-41. PubMed ID: 7748335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptors: protein and gene structure.
    Olah ME; Ren H; Stiles GL
    Arch Int Pharmacodyn Ther; 1995; 329(1):135-50. PubMed ID: 7639615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.
    Fredholm BB; IJzerman AP; Jacobson KA; Klotz KN; Linden J
    Pharmacol Rev; 2001 Dec; 53(4):527-52. PubMed ID: 11734617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer aided comparative analysis of the binding modes of the adenosine receptor agonists for all known subtypes of adenosine receptors.
    Ivanov AA; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2007 Jan; 25(5):740-54. PubMed ID: 17095272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular cross-talk between receptors coupled to phospholipase C via pertussis toxin sensitive and insensitive G-proteins.
    Dickenson JM; Hill SJ
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):296S. PubMed ID: 8224444
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.
    Cohen FR; Lazareno S; Birdsall NJ
    Br J Pharmacol; 1996 Apr; 117(7):1521-9. PubMed ID: 8730749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of adenylyl cyclase by FPP and adenosine involves stimulatory and inhibitory adenosine receptors and g proteins.
    Fraser LR; Adeoya-Osiguwa S
    Mol Reprod Dev; 1999 Aug; 53(4):459-71. PubMed ID: 10398422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis.
    Hasrat JA; Pieters L; Claeys M; Vlietinck A; De Backer JP; Vauquelin G
    J Nat Prod; 1997 Jun; 60(6):638-41. PubMed ID: 9214739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purinergic receptors.
    Malec D
    Pol J Pharmacol; 1996; 48(5):457-65. PubMed ID: 9112687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of G(s) in doubly G(s)/G(i)-coupled chimaeric A(1)/A(2A) adenosine receptors in HEK-293 cells.
    Tucker AL; Jia LG; Holeton D; Taylor AJ; Linden J
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):203-10. PubMed ID: 11062074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of di- and tri-substituted adenosine derivatives and their affinities at human adenosine receptor subtypes.
    Volpini R; Camaioni E; Costanzi S; Vittori S; Klotz KN; Cristalli G
    Nucleosides Nucleotides; 1999; 18(11-12):2511-20. PubMed ID: 10639752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.